HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The ACCURE-trial: the effect of appendectomy on the clinical course of ulcerative colitis, a randomised international multicenter trial (NTR2883) and the ACCURE-UK trial: a randomised external pilot trial (ISRCTN56523019).

AbstractBACKGROUND:
Over the past 20 years evidence has accumulated confirming the immunomodulatory role of the appendix in ulcerative colitis (UC). This led to the idea that appendectomy might alter the clinical course of established UC. The objective of this body of research is to evaluate the short-term and medium-term efficacy of appendectomy to maintain remission in patients with UC, and to establish the acceptability and cost-effectiveness of the intervention compared to standard treatment.
METHODS/DESIGN:
These paired phase III multicenter prospective randomised studies will include patients over 18 years of age with an established diagnosis of ulcerative colitis and a disease relapse within 12 months prior to randomisation. Patients need to have been medically treated until complete clinical (Mayo score <3) and endoscopic (Mayo score 0 or 1) remission. Patients will then be randomised 1:1 to a control group (maintenance 5-ASA treatment, no appendectomy) or elective laparoscopic appendectomy plus maintenance treatment. The primary outcome measure is the one year cumulative UC relapse rate - defined both clinically and endoscopically as a total Mayo-score ≥5 with endoscopic subscore of 2 or 3. Secondary outcomes that will be assessed include the number of relapses per patient at 12 months, the time to first relapse, health related quality of life and treatment costs, and number of colectomies in each arm.
DISCUSSION:
The ACCURE and ACCURE-UK trials will provide evidence on the role and acceptability of appendectomy in the treatment of ulcerative colitis and the effects of appendectomy on the disease course.
TRIAL REGISTRATION:
NTR2883 ; ISRCTN56523019.
AuthorsTjibbe J Gardenbroek, Thomas D Pinkney, Saloomeh Sahami, Dion G Morton, Christianne J Buskens, Cyriel Y Ponsioen, Pieter J Tanis, Mark Löwenberg, Gijs R van den Brink, Ivo Amj Broeders, Paul Hjm Pullens, Tom Seerden, Maarten J Boom, Rosalie C Mallant-Hent, Robert Egjm Pierik, Juda Vecht, Meindert N Sosef, Annick B van Nunen, Bart A van Wagensveld, Pieter Cf Stokkers, Michael F Gerhards, Jeroen M Jansen, Yair Acherman, Annekatrien Ctm Depla, Guido Hh Mannaerts, Rachel West, Tariq Iqbal, Shrikanth Pathmakanthan, Rebecca Howard, Laura Magill, Baljit Singh, Ye Htun Oo, Dmitri Negpodiev, Marcel Gw Dijkgraaf, Geert Ram D'Haens, Willem A Bemelman
JournalBMC surgery (BMC Surg) Vol. 15 Pg. 30 (Mar 18 2015) ISSN: 1471-2482 [Electronic] England
PMID25887789 (Publication Type: Clinical Trial, Phase III, Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
Topics
  • Adult
  • Aged
  • Aged, 80 and over
  • Appendectomy (methods)
  • Clinical Protocols
  • Colitis, Ulcerative (surgery)
  • Female
  • Humans
  • Laparoscopy
  • Male
  • Middle Aged
  • Pilot Projects
  • Prospective Studies
  • Quality of Life
  • Recurrence
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: